Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 44 results.
User Information
Export Records
  1. 1.   Can incorporating genotyping data into efficacy estimators improve efficiency of early phase malaria vaccine trials?
  2. Potter, Gail E; Callier,Viviane; Shrestha, Biraj; Joshi, Sudhaunshu; Dwivedi, Ankit; Silva, Joana C; Laurens, Matthew B; Follmann, Dean A; Deye, Gregory A
  3. Malaria Journal. 2023, Dec 19; 22(1): 383.
  1. 2.   CD47-Dependent Regulation of Immune Checkpoint Gene Expression and MYCN mRNA Splicing in Murine CD8 and Jurkat T Cells
  2. Kaur, Sukhbir; Awad, Duha; Finney, Richard P; Meyer, Thomas J; Singh, Satya P; Cam, Margaret C; Karim,Baktiar; Warner,Andrew; Roberts, David D
  3. International Journal of Molecular Sciences. 2023, Jan 30; 24(3):
  1. 3.   Context-Dependent Function of Long Noncoding RNA PURPL in Transcriptome Regulation during p53 Activation
  2. Hartford, Corrine Corrina R; Shrestha, Roshan L; Pongor, Lorinc; Zhao,Yongmei; Chen, Xiongfong; Fromont,Caroline; Chaudhary, Ritu; Li, Xiao Ling; Pasterczyk, Katherine R; Kumar, Ravi; Muys, Bruna R; Tsitsipatis, Dimitrios; Chari,Raj; Gorospe, Myriam; Aladjem, Mirit I; Khan, Javed; Basrai, Munira A; Grammatikakis, Ioannis; Lal, Ashish
  3. Molecular and Cellular Biology. 2022, Nov 07; 42(12): e0028922.
  1. 4.   Multiparameter immunohistochemistry analysis of HIV DNA, RNA and immune checkpoints in lymph node tissue
  2. Richardson, Zuwena A; Deleage,Claire; Tutuka, Candani S A; Walkiewicz, Marzena; Del Río-Estrada, Perla M; Pascoe, Rachel D; Evans, Vanessa A; Reyesteran, Gustavo; Gonzales, Michael; Roberts-Thomson, Samuel; González-Navarro, Mauricio; Torres-Ruiz, Fernanda; Estes, Jacob D; Lewin, Sharon R; Cameron, Paul U
  3. Journal of Immunological Methods. 2021, Dec 01; 113198.
  1. 5.   Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019
  2. Richard, Stephanie A; Epsi, Nusrat J; Pollett, Simon; Lindholm, David A; Malloy, Allison M W; Maves, Ryan; Utz, Gregory C; Lalani, Tahaniyat; Smith, Alfred G; Mody, Rupal M; Ganesan, Anuradha; Colombo, Rhonda E; Colombo, Christopher J; Chi, Sharon W; Huprikar, Nikhil; Larson, Derek T; Bazan, Samantha; Madar, Cristian; Lanteri, Charlotte; Rozman, Julia S; English, Caroline; Mende, Katrin; Tribble, David R; Agan, Brian K; Burgess, Timothy H; Powers,John
  3. Open Forum Infectious Diseases. 2021, Oct 8; 8(12): ofab517.
  1. 6.   Overproduction of a dominant mutant of the conserved Era GTPase inhibits cell division in Escherichia coli
  2. Zhou, Xiaomei; Peters, Howard K; Li,Xintian; Costantino,Nina; Kumari,Vandana; Shi,Genbin; Tu, Chao; Cameron, Todd A; Haeusser, Daniel P; Vega, Daniel E; Ji, Xinhua; Margolin, William; Court,Don
  3. Journal of bacteriology. 2020, NOV; 202(21): pii: JB.00342-20.
  1. 7.   Endpoints for randomized controlled clinical trials for COVID-19 treatments
  2. Dodd, Lori E; Follmann, Dean; Wang,Jing; Koenig, Franz; Korn, Lisa L; Schoergenhofer, Christian; Proschan, Michael; Hunsberger, Sally; Bonnett,Tyler; Makowski, Mat; Belhadi, Drifa; Wang, Yeming; Cao, Bin; Mentre, France; Jaki, Thomas
  3. Clinical trials (London, England). 2020, Jul 16; pii: 1740774520939938.
  1. 8.   Mutations in the HPV16 genome induced by APOBEC3 are associated with viral clearance
  2. Zhu, Bin; Xiao, Yanzi; Yeager,Meredith; Clifford, Gary; Wentzensen, Nicolas; Cullen,Michael; Boland,Joseph; Bass,Sara; Steinberg,Mia; Raine-Bennett, Tina; Lee, DongHyuk; Burk, Robert D; Pinheiro, Maisa; Song,Lei; Dean, Michael; Nelson, Chase W; Burdett,Laurie; Yu, Kai; Roberson, David; Lorey, Thomas; Franceschi, Silvia; Castle, Philip E; Walker, Joan; Zuna, Rosemary; Schiffman, Mark; Mirabello, Lisa
  3. Nature communications. 2020, Feb 14; 11(1): pii: 10.1038/s41467-020-14730-1.
  1. 9.   Evaluation of Pharmacodynamic Responses to Cancer Therapeutic Agents Using DNA Damage Markers
  2. Wilsker,Deborah; Barrett, Allison M.; Dull,Angie; Lawrence,Scott; Hollingshead,Melinda; Chen, Alice; Kummar, Shivaani; Parchment,Ralph; Doroshow, James H.; Kinders,Robert
  3. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019, MAY 15; 25(10): 3084-3095.
  1. 10.   Bridging the Gap: Moving Predictive and Prognostic Assays from Research to Clinical Use
  2. Williams, P. M.; Lively, T. G.; Jessup, J. M.; Conley, B. A.
  3. Clinical Cancer Research. 2012, Mar; 18(6): 1531-1539.
  1. 11.   Development of a Validated Immunofluorescence Assay for gamma H2AX as a Pharmacodynamic Marker of Topoisomerase I Inhibitor Activity
  2. Kinders, R. J.; Hollingshead, M.; Lawrence, S.; Ji, J. P.; Tabb, B.; Bonner, W. M.; Pommier, Y.; Rubinstein, L.; Evrard, Y. A.; Parchment, R. E.; Tomaszewski, J.; Doroshow, J. H.; Natl Canc Inst Phase 0 Clinical, T.
  3. Clinical Cancer Research. 2010, Nov; 16(22): 5447-5457.
  1. 12.   Guidelines for the Development and Incorporation of Biomarker Studies in Early Clinical Trials of Novel Agents
  2. Dancey, J. E.; Dobbin, K. K.; Groshen, S.; Jessup, J. M.; Hruszkewycz, A. H.; Koehler, M.; Parchment, R.; Ratain, M. J.; Shankar, L. K.; Stadler, W. M.; True, L. D.; Gravell, A.; Grever, M. R.; Biomarkers Task Force, N. C. I. I.
  3. Clinical Cancer Research. 2010, Mar; 16(6): 1745-1755.
  1. 13.   A dual role of Cdk2 in DNA damage response
  2. Satyanarayana, A.; Kaldis, P.
  3. Cell Division. 2009, May; 4: 4.
  1. 14.   Role of GADD34 in modulation of cisplatin cytotoxicity
  2. Fishel, M. L.; Rabik, C. A.; Bleibel, W. K.; Li, X. M.; Moschel, R. C.; Dolan, M. E.
  3. Biochemical Pharmacology. 2006, JAN 12; 71(3): 239-247.
  1. 15.   Analysis of mass spectral serum profiles for biomarker selection
  2. Ressom, H. W.; Varghese, R. S.; bdel-Hamid, M.; Eissa, S. A. L.; Saha, D.; Goldman, L.; Petricoin, E. F.; Conrads, T. P.; Veenstra, T. D.; Loffredo, C. A.; Goldman, R.
  3. Bioinformatics. 2005, NOV 1; 21(21): 4039-4045.
  1. 16.   WMC-79, a potent agent against colon cancers, induces apoptosis through a p53-dependent pathway
  2. Kosakowska-Cholody, T.; Cholody, W. M.; Monks, A.; Woynarowska, B. A.; Michejda, C. J.
  3. Molecular Cancer Therapeutics. 2005, OCT; 4(10): 1617-1627.
  1. 17.   Whole cell segmentation in solid tissue sections
  2. Baggett, D.; Nakaya, M. A.; McAuliffe, M.; Yamaguchi, T. P.; Lockett, S.
  3. Cytometry Part A. 2005, OCT; 67A(2): 137-143.
  1. 18.   A rhesus macaque radiation hybrid map and comparative analysis with the human genome
  2. Murphy, W. J.; Agarwala, R.; Schaffer, A. A.; Stephens, R.; Smith, C.; Crumpler, N. J.; David, V. A.; O'Brien, S. J.
  3. Genomics. 2005, OCT; 86(4): 383-395.
  1. 19.   Epstein-Barr virus-encoded latent membrane protein 1 modulates cyclin D1 by c-Jun/Jun B heterodimers
  2. Song, X.; Tao, Y. G.; Zeng, L.; Yang, J.; Tang, F. Q.; Lee, L. M.; Gong, J. P.; Wu, Q.; Cao, Y.
  3. Science in China Series C-Life Sciences. 2005, AUG; 48(4): 385-393.
  1. 20.   Microarray analysis of altered gene expression in murine fibroblasts transformed by nickel(II) to nickel(II)-resistant malignant phenotype
  2. Kowara, R.; Karaczyn, A.; Cheng, R. Y. S.; Salnikow, K.; Kasprzak, K. S.
  3. Toxicology and Applied Pharmacology. 2005, MAY 15; 205(1): 1-10.
  1. 21.   The B30.2(SPRY) domain of the retroviral restriction factor TRIM5 alpha exhibits line age-specific length and sequence variation in primates
  2. Song, B. W.; Gold, B.; O'HUigin, C.; Javanbakht, H.; Li, X.; Stremlau, M.; Winkler, C.; Dean, M.; Sodroski, J.
  3. Journal of Virology. 2005, MAY; 79(10): 6111-6121.
  1. 22.   Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver
  2. Nakai, H.; Wu, X. L.; Fuess, S.; Storm, T. A.; Munroe, D.; Montini, E.; Burgess, S. M.; Grompe, M.; Kay, M. A.
  3. Journal of Virology. 2005, MAR; 79(6): 3606-3614.
  1. 23.   Mapping genomic rearrangements in titi monkeys by chromosome flow sorting and multidirectional in-situ hybridization
  2. Dumas, F.; Bigoni, F.; Stone, G.; Sineo, L.; Stanyon, R.
  3. Chromosome Research. 2005 13(1): 85-96.
  1. 24.   Preclinical manufacture of anti-HER2 liposome-inserting, scFv-PEG-Lipid conjugate. 2. Conjugate micelle identity, purity, stability, and potency analysis
  2. Nellis, D. F.; Giardina, S. L.; Janini, G. M.; Shenoy, S. R.; Marks, J. D.; Tsai, R.; Drummond, D. C.; Hong, K.; Park, J. W.; Ouellette, T. F.; Perkins, S. C.; Kirpotin, D. B.
  3. Biotechnology Progress. 2005, JAN-FEB; 21(1): 221-232.
  1. 25.   Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells
  2. Shivakrupa, R.; Linnekin, D.
  3. Cellular Signalling. 2005, JAN; 17(1): 103-109.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel